Literature DB >> 30151596

Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes.

Nicolas Quesnot1,2, Simon Bucher1, Christina Gade3, Manuel Vlach1, Elise Vene1, Samuel Valença2, Thomas Gicquel1, Helle Holst3, Marie-Anne Robin1, Pascal Loyer4,5.   

Abstract

CYP2E1 activity is measured in vitro and in vivo via hydroxylation of the Chlorzoxazone (CHZ) producing the 6-hydroxychlorzoxazone (OH-CHZ) further metabolized as a glucuronide excreted in urine. Thus, the quantification of the OH-CHZ following enzymatic hydrolysis of CHZ-derived glucuronide appears to be a reliable assay to measure the CYP2E1 activity without direct detection of this glucuronide. However, OH-CHZ hydrolyzed from urinary glucuronide accounts for less than 80% of the CHZ administrated dose in humans leading to postulate the production of other unidentified metabolites. Moreover, the Uridine 5'-diphospho-glucuronosyltransferase (UGT) involved in the hepatic glucuronidation of OH-CHZ has not yet been identified. In this study, we used recombinant HepG2 cells expressing CYP2E1, metabolically competent HepaRG cells, primary hepatocytes and precision-cut human liver slices to identify metabolites of CHZ (300 μM) by high pressure liquid chromatography-UV and liquid-chromatography-mass spectrometry analyses. Herein, we report the detection of the CHZ-O-glucuronide (CHZ-O-Glc) derived from OH-CHZ in culture media but also in mouse and human urine and we identified a novel CHZ metabolite, the CHZ-N-glucuronide (CHZ-N-Glc), which is resistant to enzymatic hydrolysis and produced independently of CHZ hydroxylation by CYP2E1. Moreover, we demonstrate that UGT1A1, 1A6 and 1A9 proteins catalyze the synthesis of CHZ-O-Glc while CHZ-N-Glc is produced by UGT1A9 specifically. Together, we demonstrated that hydrolysis of CHZ-O-Glc is required to reliably quantify CYP2E1 activity because of the rapid transformation of OH-CHZ into CHZ-O-Glc and identified the CHZ-N-Glc produced independently of the CYP2E1 activity. Our results also raise the questions of the contribution of CHZ-N-Glc in the overall CHZ metabolism and of the quantification of CHZ glucuronides in vitro and in vivo for measuring UGT1A activities.

Entities:  

Keywords:  CYP2E1; Chlorzoxazone; Drug metabolism; Glucuronides; UGT

Mesh:

Substances:

Year:  2018        PMID: 30151596     DOI: 10.1007/s00204-018-2300-2

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  4 in total

1.  Preparation of a mimetic and degradable poly(ethylene glycol) by a non-eutectic mixture of organocatalysts (NEMO) via a one-pot two-step process.

Authors:  S Moins; P Loyer; J Odent; O Coulembier
Journal:  RSC Adv       Date:  2019-12-04       Impact factor: 4.036

2.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

3.  New insights into quetiapine metabolism using molecular networking.

Authors:  Brendan Le Daré; Pierre-Jean Ferron; Pierre-Marie Allard; Bruno Clément; Isabelle Morel; Thomas Gicquel
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

Review 4.  Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver.

Authors:  Julie Massart; Karima Begriche; Jessica H Hartman; Bernard Fromenty
Journal:  Cells       Date:  2022-01-15       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.